Insilico Medicine has launched a DDD Benchmark as a Service to test frontier AI and foundation models against real-world drug discovery and development tasks.

MIT researchers develop language model for codon optimization, boosting protein production including trastuzumab by 25-300%, published in PNAS.

MIT Professor Jim Collins leads groundbreaking research using generative AI to design programmable antibacterials targeting drug-resistant pathogens.